Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000190592 | SCV000245618 | other | Tay-Sachs disease | 2014-05-30 | criteria provided, single submitter | clinical testing | pseudodeficiency |
Eurofins Ntd Llc |
RCV000375852 | SCV000331536 | other | not provided | 2016-07-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000375852 | SCV000697174 | benign | not provided | 2016-08-11 | criteria provided, single submitter | clinical testing | Variant summary: The HEXA c.745C>T (p.Arg249Trp) variant causes a missense change involving a conserved nucleotide with 5/5 in silico tools predicting a damaging outcome. The variant of interest was found in the large, broad control population, ExAC, with an allele frequency of 28/121408 (1/4336), which does not exceed the estimated maximal expected allele frequency for a pathogenic HEXA variant of 1/715. The variant of interest is known to be a common pseudodeficiency allele, which is not associated with neurologic disease but is associated wtih reduced degradation of the synthetic substrate when HEX A enzymatic activity is determined (Gene Reviews). Therefore, the variant of interest is classified as Benign. |
Invitae | RCV000190592 | SCV000933533 | other | Tay-Sachs disease | 2018-12-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000375852 | SCV004698536 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | HEXA: PM2:Supporting |